Article
H3K27-altered diffuse midline gliomas with MAPK pathway alterations: Prognostic and therapeutic implications.
Journal of neuropathology and experimental neurology - 22 Dec 2023
Gestrich Catherine, Grieco Kristina, Lidov Hart G, Baird Lissa C, Fehnel Katie P, Yeo Kee Kiat, Meredith David M, Alexandrescu Sanda
Abstract excerpt
Large-scale sequencing led to the identification of driver molecular alterations such as FGFR1 and BRAF in occasional diffuse midline gliomas (DMGs) H3K27-mutant but their significance has not been completely explored. We evaluated these associations in our institutional cohorts. We searched our archives for H3K2M7-mutant gliomas and analyzed the co-occurring genetic alterations. The demographics, clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
